SANGSTAT MEDICAL CORP·4

Sep 15, 7:03 PM ET

DANCE STEPHEN G 4

4 · SANGSTAT MEDICAL CORP · Filed Sep 15, 2003

Insider Transaction Report

Form 4
Period: 2003-09-11
DANCE STEPHEN G
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2003-09-11$8.07/sh+38,528$310,92138,528 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$19.38/sh+28,749$557,15628,749 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh28,749$646,8530 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$8.07/sh+11,472$92,57911,472 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh10,000$225,0000 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh38,528$866,8800 total
  • Exercise/Conversion

    Common Stock

    2003-09-11$15.00/sh+10,000$150,0001,000 total
  • Disposition to Issuer

    Common Stock

    2003-09-11$22.50/sh11,472$258,1200 total
Footnotes (1)
  • [F1]Option vesting was accelerated and the underlying common stock and all other common stock owned by the reporting person was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION